Pyxis Oncology, Inc. (PYXS) Misses Q4 EPS by 100c

Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q4 EPS of ($1.32), $1.00 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.

You May Also Be Interested In

• FinVolution (FINV) PT Lowered to $4.70 at Jefferies
• Deutsche Bank Upgrades Ningbo Xusheng Group Co Ltd (603305:CH) to Hold
• CLSA Upgrades Baozun (BZUN) to Outperform (2)